Hide Board Information

Show Board Information

Easton Pharmaceuticals Inc EAPH

Board Mod: RIPPER

Asst Mods:

Last Post: 06/13/2019 4:05:41 PM

Board Marks: 21

Posts Today: 0

Board Views Today: 49

Easton Pharmaceuticals Inc. (EAPH)

Company Website: http://www.eastonpharma.com/

Easton Pharmaceuticals Inc (OTCMRKTS: EAPH) Stock Message Board

1. EAPH Company Profile

    

2. EAPH Time & Sales

    

3. EAPH Recent News

    

4. EAPH Filings

    

5. EAPH Financials

    

6. EAPH Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	FDA approval	RIPPER	04/21/2013 1:13:32 PM
1	unknown but going to fly this	RIPPER	04/21/2013 1:13:12 PM

Newer

Recent Articles

• Leeward Renewable Energy's Q3 2024 Financial Results Update
• Union Pacific Corporation Announces Consistent Dividend Commitment
• Pinnacle Bancshares Announces $0.27 Quarterly Dividend for Shareholders
• Regional Management Corp. Achieves Milestone with New Securitization
• BNY Mellon Municipal Funds Announce Monthly Distributions
• Sandstorm Gold Enhances Production and Key Developments Update
• Valante Capital Strengthens Position with American Foods Acquisition
• Essential Steps for Securing Your Construction Loan Guide
• Digital Ally, Inc. Improves Compliance After Nasdaq Notification
• Royalty Pharma Expands Investor Engagement with Conferences
• ARMOUR Residential REIT Enhances December Dividend for Shareholders
• Quanex Building Products to Share 2024 Earnings Insights Soon
• Fundamental Global Inc. Announces Exciting Cash Dividend Update
• OneMedNet Corporation Faces Nasdaq Compliance Challenge
• Nutanix Set to Showcase Innovations at Key Investor Event
• Coherus BioSciences: Insights on Upcoming Healthcare Panel
• Marten Transport Announces Consistent Quarterly Dividend Payout
• Wing Yip Food Holdings Complete First Public Offering Success
• Globus Maritime to Announce Q3 and Nine-Month Results Soon
• Windtree Therapeutics Unveils Recent Financial Update and Insights
• Revolution Medicines to Update on Innovative RAS(ON) Therapies
• Sensei Biotherapeutics Eyes Opportunities at Upcoming Conference
• Atara Biotherapeutics Set to Showcase Innovations at Key Conference
• Innovative Tools from QIAGEN Revolutionize Microbial Analysis
• Parsons Corporation Engages Investors at Upcoming Conferences
• Glancy Prongay & Murray Probes ICON Public Limited Company Violations
• Titan Pharmaceuticals Faces Compliance Challenges with Nasdaq
• Exploring Opportunities for Hasbro, Inc. Investors Amidst Recent Lawsuit
• Applied Therapeutics Updates on Govorestat FDA Response
• Investigation of MediaAlpha, Inc. Sparks Attention for Investors
• Investigation Into Marqeta, Inc.: Key Insights for Investors
• Regeneron Pharmaceuticals Under Investigation by GPM: What Investors Need to Know
• PACS Group, Inc. Faces Class Action Amid Allegations of Fraud
• Investigation into Franklin Resources Signals Investor Concerns
• First Trust Advisors L.P. Declares Monthly Distribution for ETF
• Revolutionizing Robotics: WorkFar's Remarkable Journey Ahead
• Harley-Davidson Announces Fourth Quarter Dividend for 2024
• ASML Holding NV Class Action: What Investors Need to Know
• Boardwalktech Software: Fiscal 2025 Q2 Results Overview
• Transforming Tupperware: A New Era for Party Products LLC
• Kewaunee Scientific Corporation Announces Upcoming Earnings
• Ramaco Resources Closes Senior Unsecured Notes Offering Successfully
• iClick Interactive Reports Strong Half-Year Financial Performance
• Ohio Senator's Visit Highlights Blossom Hill's Impact on Disabled Community
• Revolutionizing Steel Maintenance: Laser Photonics CleanTech
• WellRX Enhances Preventative Care With Bioreach Acquisition
• Insights for Investors in Warner Bros. Discovery, Inc. (WBD)
• Experience the Thrill of Survival with PattieSquidGame Season 2
• Rumble Challenges California's Censorship Law in Court
• APPlife Digital Solutions Ends Collaboration with Silver Bear